SCHEMBL370014

SCHEMBL370014

Brc1c2ccccc2n2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.38
FYN P06241 1/20 0.38
PDGFRB P09619 1/20 0.38
PIM1 P11309 1/20 0.38
FGFR1 P11362 1/20 0.38
GRK5 P34947 1/20 0.38
KDR P35968 1/20 0.38
MAP2K2 P36507 1/20 0.38
MAPK8 P45983 1/20 0.38
CDK8 P49336 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
NEK2 P51955 1/20 0.38
MAP2K1 Q02750 1/20 0.38
BTK Q06187 1/20 0.38
TYRO3 Q06418 1/20 0.38
TNK2 Q07912 1/20 0.38
MAP4K2 Q12851 1/20 0.38
IKBKE Q14164 1/20 0.38
LRRK2 Q5S007 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12092119 0.75 GPR3 (0.48) GPR3KDM4EALDH1A1L3MBTL1MAPT
SCHEMBL25634887 0.75 GPR3 (0.48) GPR3KDM4EALDH1A1L3MBTL1MAPT
SCHEMBL370015 0.70 KDM4E (0.37) KDM4EALDH1A1L3MBTL1MAPTGAA
SCHEMBL25534613 0.70 PTGS2 (0.41) CHEK1KDM4EALDH1A1L3MBTL1MAPT
SCHEMBL365090 0.68 ALDH1A1 (0.68) KDM4EALDH1A1L3MBTL1MAPTGAA
SCHEMBL20561425 0.67 PTPN1 (0.39) CHEK1GPR3KDM4EALDH1A1L3MBTL1
SCHEMBL371112 0.67 IDO1 (0.51) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL25635341 0.65 GPR3 (0.37) GPR3KDM4EALDH1A1L3MBTL1MAPT
SCHEMBL25634885 0.65 GPR3 (0.42) GPR3KDM4EALDH1A1L3MBTL1MAPT
SCHEMBL12859617 0.65 GPR3 (0.42) CHEK1GPR3KDM4EALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151032-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-18 US disclosed
US-20230151032-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-18 US disclosed
WO-2012007007-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151032-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE CRY1, CYP1A1, CYP2E1 CHEK1 2075/4885FYN 4200/4885PDGFRB 4194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.